Myocardial dysfunction in severe sepsis and septic shock: More questions than answers?

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 25, Issue 3, 2011, Pages 526-535

  Hochstadt, Aviram ^a   Meroz, Yuval ^a   Landesberg, Giora ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; COMPLEMENT COMPONENT C5A; CYTOKINE; ENDOTOXIN; HEART MUSCLE DEPRESSANT FACTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; NITRIC ACID; NITRIC OXIDE SYNTHASE; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTERIAL PRESSURE; ARTERY THROMBOSIS; AUTONOMIC NERVOUS SYSTEM FUNCTION; BACTERIAL INFECTION; BLOOD CLOTTING DISORDER; CALCIUM TRANSPORT; CARDIOVASCULAR RESPONSE; DIASTOLIC DYSFUNCTION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ECHOCARDIOGRAPHY; ENZYME INHIBITION; FLUID THERAPY; HEART INDEX; HEART LEFT VENTRICLE DIASTOLIC DYSFUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE SYSTOLIC DYSFUNCTION; HEART MITOCHONDRION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HEART RIGHT VENTRICLE ENDSYSTOLIC VOLUME; HEART RIGHT VENTRICLE FAILURE; HEART STROKE VOLUME; HEMODILUTION; HEMODYNAMIC MONITORING; HIGH OUTPUT HEART FAILURE; HUMAN; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; REVIEW; SEPSIS; SEPTIC SHOCK; STARLING LAW; SYSTEMIC VASCULAR RESISTANCE; SYSTOLIC DYSFUNCTION; VENOUS PRESSURE; VENOUS RETURN;

ANIMALS; CARDIOMYOPATHIES; FLUID THERAPY; HEART FAILURE; HUMANS; SEPSIS; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC;

EID: 79957753122     PISSN: 10530770     EISSN: 15328422     Source Type: Journal    
DOI: 10.1053/j.jvca.2010.11.026     Document Type: Review

References (117)

1. Wenzel RP: Treating sepsis. N Engl J Med 347:966-967, 2002
2. Parrillo JE: Pathogenetic mechanisms of septic shock. N Engl J Med 328:1471-1477, 1993
3. Rudiger A, Singer M: Mechanisms of sepsis induced cardiac dysfunction. Crit Care Med 35:1599-1608, 2007 (Pubitemid 46809326)
4. Hunter JD, Doddi M: Sepsis and the heart. Br J Anaesth 104:3-11, 2010
5. Zanotti-Cavazzoni SL, Hollenberg SM: Cardiac dysfunction in severe sepsis and septic shock. Curr Opin Crit Care 15:392-397, 2009
6. Weil MH, MacLean LD, Visscher MB: Studies on the circulatory changes in the dog produced by endotoxin from Gram-negative microorganisms. J Clin Invest 35:1191-1198, 1956
7. Hinshaw LB, Sanbour LL, Greefield LJ, et al: Mechanisms of decreased venous return: Subhuman primate-administered endotoxin. Arch Surg 100:600-606, 1970
8. Bockman SK, Thomas CS, Vasko JS: Escherichia coli endotoxin on the circulation. Surg Gynecol Obstet 125:763-774, 1967
9. Teule GJ, den Hollander W, Bronsveld W, et al: Effect of volume loading and dopamine on hemodynamics and red-cell redistribution in canine endotoxin shock. Circ Shock 10:41-50, 1983 (Pubitemid 13176347)
10. Carroll GC, Snyder JV: Hyperdynamic severe intravascular sepsis depends on fluid administration in cynomolgus monkey. Am J Physiol 243:R131-R141, 1982 (Pubitemid 12092171)
11. Rabuel C, Mebazaa A: Septic shock: A heart story since the 1960s. Intensive Care Med 32:799-807, 2006 (Pubitemid 43781360)
12. Winslow EJ, Loeb HS, Rahimtoola SH, et al: Hemodynamic studies and results of therapy in 50 patients with bacteremic shock. Am J Med 54:421-432, 1973
13. Weisel RD, Vito L, Dennis RC, et al: Myocardial depression during sepsis. Am J Surg 133:512-521, 1977 (Pubitemid 8089220)
14. Krausz MM, Perel A, Eimerl D, et al: Cardiopulmonary effects of volume loading in patients in septic shock. Ann Surg 185:429-434, 1977 (Pubitemid 8069869)
15. Suffredini AF, Fromm RE, Parker MM, et al: The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 321:280-287, 1989 (Pubitemid 19193802)
16. Kumar A, Anel R, Bunnell E, et al: Preload-independent mechanisms contribute to increased stroke volume following large volume saline infusion in normal volunteers: A prospective interventional study. Crit Care 8:R128-R136, 2004
17. Rivers E, Nguyen B, Havstad S, et al: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368-1377, 2001
18. Groeneveld AB, Bronsveld W, Thijs LG: Hemodynamic determinants of mortality in human septic shock. Surgery 99:140-152, 1986 (Pubitemid 16144912)
19. Brandt S, Regueira T, Bracht H, et al: Effect of fluid resuscitation on mortality and organ function in experimental sepsis models. Crit Care 13:R186, 2009
20. Spronk PE, Zandstra DF, Ince C: Bench-to-bedside review: Sepsis is a disease of the microcirculation. Crit Care 8:462-468, 2004 (Pubitemid 40073681)
21. Harrison LH, Beller JJ, Hinshaw LB, et al: Effects of endotoxin on pulmonary capillary permeability ultra structure and surfactant. Surg Gynecol Obstet 129:723, 1969
22. Taveira da Silva AM, Kaulbach HC, et al: Brief report: Shock and multiple-organ dysfunction after self-administration of Salmonella endotoxin. N Engl J Med 328:1457-1460, 1993
23. Tom WW, Villalba M, Szlabick RE, et al: Fluorophotometric evaluation of capillary permeability in gram-negative shock. Arch Surg 118:636-641, 1983 (Pubitemid 13079306)
24. Elbers PWG, Ince C: Bench-to-bedside review: Mechanisms of critical illness - Classifying microcirculatory flow abnormalities in distributive shock. Crit Care 10:221, 2006
25. Groner W, Winkelman JW, Harris AG, et al: Orthogonal polarization spectral imaging: A new method for study of the microcirculation. Nat Med 5:1209-1212, 1999
26. De Backer D, Creteur J, Preiser JC, et al: Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med 166:98-104, 2002 (Pubitemid 34693970)
27. Sakr Y, Dubois MJ, De Backer D, et al: Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med 32:1825-1831, 2004
28. Verdant CL, De Backer D, Bruhn A, et al: Evaluation of sublingual and gut mucosal microcirculation in sepsis: A quantitative analysis. Crit Care Med 37:2875-2881, 2003
29. Suffredini AF, Shelhamer JH, Neumann RD, et al: Pulmonary and oxygen transport effects of intravenously administered endotoxin in normal humans. Am Rev Resp Dis 145:1398-1403, 1992
30. van Eijk LTGJ, Pickkers P, Smits P, et al: Microvascular permeability during experimental human endotoxemia: An open intervention study. Crit Care 9:R157-R164, 2005
31. Parker MM, Shelhamer JH, Bacharach SL, et al: Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 100:483-490, 1984 (Pubitemid 14126735)
32. Ognibene FP, Parker MM, Natanson C, et al: Depressed left ventricular performance. Response to volume infusion in patients with sepsis and septic shock. Chest 93:903-910, 1988
33. Fernandes CJ Jr, Iervolino M, Neves RA, et al: Interstitial myocarditis in sepsis. Am J Cardiol 74:958, 1994 (Pubitemid 24340326)
34. Kumar A, Bunnell E, Lynn M, et al: Experimental human endotoxemia is associated with depression of load-independent contractility indices: Prevention by the lipid A analogue E5531. Chest 126:860-867, 2004 (Pubitemid 39258042)
35. Lefer AM: Mechanisms of cardiodepression in endotoxin shock. Circ Shock 1:l-8, 1979 (suppl)
36. Kober PM, Thomas JX Jr, Raymond RA: Increased myocardial contractility during endotoxin shock in dogs. Am J Physiol 249:H715-H722, 1985 (Pubitemid 16207211)
37. Papadakis EJ, Abel FL: Left ventricular performance in canine endotoxin shock. Circ Shock 24:123-131, 1988 (Pubitemid 18087081)
38. Kober PM, Thomas JX Jr, Raymond RM: Increased myocardial contractility during endotoxin shock in dogs. Am J Physiol 249:H715-H722, 1985 (Pubitemid 16207211)
39. Teule GJ, van Lingen A, Schneider AJ, et al: Left and right ventricular function in porcine Escherichia coli sepsis. Circ Shock 15:185-192, 1985 (Pubitemid 15136532)
40. Hinshaw LB, Archer LT, Greenfield LJ, et al: Am J Physiol 221:504-510, 1971
41. Ozier Y, Guéret P, Jardin F, et al: Two-dimensional echocardiographic demonstration of acute myocardial depression in septic shock. Crit Care Med 12:596-599, 1984 (Pubitemid 14087413)
42. Jardin F, Brun-Ney D, Auvert B, et al: Sepsis-related cardiogenic shock. Crit Care Med 18:1055-1060, 1990 (Pubitemid 20364040)
43. Jardin F, Fourme T, Page B, et al: Persistent preload defect in severe sepsis despite fluid loading: A longitudinal echocardiographic study in patients with septic shock. Chest 116:1354-1359, 1999 (Pubitemid 29535992)
44. Vieillard-Baron A, Schmitt JM, Beauchet A, et al: Early preload adaptation in septic shock? A transesophageal echocardiographic study. Anesthesiology 94:400-406, 2001 (Pubitemid 32198445)
45. Etchecopar-Chevreuil C, Franĉois B, Clavel M, et al: Cardiac morphological and functional changes during early septic shock: A transesophageal echocardiographic study. Intensive Care Med 34:250-256, 2008
46. Vieillard-Baron A, Caille V, Charron C, et al: Actual incidence of global left ventricular hypokinesia in adult septic shock. Crit Care Med 36:1701-1706, 2008
47. Bouhemad B, Nicolas-Robin A, Arbelot C, et al: Acute left ventricular dilatation and shock-induced myocardial dysfunction. Crit Care Med 37:441-447, 2009
48. Nagueh SF, Appleton CP, Gillebert TC, et al: Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 10:165-193, 2009
49. Libonati JR: Myocardial diastolic function and exercise. Med Sci Sports Exerc 31:1741-1747, 1999
50. Poelaert J, Declerck C, Vogelaers D, et al: Left ventricular systolic and diastolic function in septic shock. Intensive Care Med 23:553-560, 1997 (Pubitemid 27263068)
51. Murat B, Jue J, Gin K, et al: Diastolic filling in human severe sepsis: An echocardiographic study. Crit Care Med 26:1829-1833, 1998
52. Bouhemad B, Nicolas-Robin A, Arbelot C, et al: Isolated and reversible impairment of ventricular relaxation in patients with septic shock. Crit Care Med 36:766-774, 2008
53. Marthu M, Pollard V, He G, et al: Left ventricular diastolic filling characteristics are not impaired but systolic performance was augmented in the early hours of experimental endotoxemia in humans. Shock 25:338-343, 2006
54. Chan CM, Klinger JR: The right ventricle in sepsis. Clin Chest Med 29:661-676, 2008
55. Leighton TA, Averbook AW, Klein SR, et al: Time-course of cardiopulmonary effects tumor necrosis factor and endotoxin are similar. Am Surg 57:836-842, 1991
56. Cohen RI, Shapir Y, Chen L, et al: Right ventricular overload causes the decrease in cardiac output after nitric oxide synthesis inhibition in endotoxemia. Crit Care Med 26:738-747, 1998 (Pubitemid 28201422)
57. Vlahakes GJ, Turley K, Hoffman JI: The pathophysiology of failure in right ventricular hypertension: hemodynamic and biochemical correlates. Circulation 63:87-95, 1981 (Pubitemid 11213337)
58. Moore TD, Frenneaux MP, Sas R, et al: Ventricular interaction and external constraint account for decreased stroke work during volume loading in CHF. Am J Physiol Heart Circ Physiol 281:2385-2391, 2001
59. Schneider AJ, Teule GJ, Groeneveld AB, et al: Biventricular performance during volume loading in patients with early septic shock, with emphasis on the right ventricle: A combined hemodynamic and radionuclide study. Am Heart J 116:103-112, 1988
60. Hoffman MJ, Lazar JG, Sugerman HF, et al: Unsuspected right ventricular dysfunction in shock and sepsis. Ann Surg 198:307-318, 1983
61. Parker MM, McCArthy KE, Ognibene FP, et al: Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans. Chest 97:126-131, 1990 (Pubitemid 20023505)
62. Vincent JL, Reuse C, Frank N, et al: Right ventricular dysfunction in septic shock: assessment by measurements using the thermodilution technique. Acta Anaesthesiol Scand 33:34-38, 1989 (Pubitemid 19041575)
63. Kay HR, Afshari M, Barash P, et al: Measurement of ejection fraction by thermal dilution technique. J Surg Res 34:337-340, 19831
64. Dhainaut JF, Huyghebaert MF, Monsallier JF, et al: Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in patients with septic shock. Circulation 75:533-541, 1987 (Pubitemid 17026042)
65. Cunnion RE, Schaer GL, Parker MM, et al: The coronary circulation in human septic shock. Circulation 73:637-644, 1986 (Pubitemid 16081421)
66. Groeneveld AB, van Lambalgen AA, van den Bos GC, et al: Maldistribution of heterogeneous coronary blood flow during canine endotoxin shock. Cardiovasc Res 25:80-88, 1991
67. Brealey D, Karyampudi S, Jacques TS, et al: Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure. Am J Physiol Regul Integr Comp Physiol 286:R491-R497, 2004 (Pubitemid 38252613)
68. Crouser ED, Julian MW, Huff JE, et al: Abnormal permeability of inner and outer mitochondrial membranes contributes independently to mitochondrial dysfunction in the liver during acute endotoxemia. Crit Care Med 32:478-488, 2004 (Pubitemid 38234129)
69. Brealey D, Brand M, Hargreaves I, et al: Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 360:219-223, 2002 (Pubitemid 34804650)
70. Suliman HB, Welty-Wolf KE, Carraway M, et al: Lipopolysaccharide induces oxidative cardiac mitochondrial damage and biogenesis. Cardiovasc Res 64:279-288, 2004 (Pubitemid 39361689)
71. Watts JA, Kline JA, Thornton LR, et al: Metabolic dysfunction and depletion of mitochondria in hearts of septic rats. J Mol Cell Cardiol 36:141-150, 2004 (Pubitemid 38084799)
72. Levy RJ, Vijayasarathy C, Raj NR, et al: Competitive and noncompetitive inhibition of myocardial cytochrome C oxidase in sepsis. Shock 21:110-114, 2004
73. Trumbeckaite S, Opalka JR, Neuhof C, et al: Different sensitivity of rabbit heart and skeletal muscle to endotoxin-induced impairment of mitochondrial function. Eur J Biochem 268:1422-1429, 2001 (Pubitemid 32231896)
74. Solomon MA, Correa R, Alexander HR, et al: Myocardial energy metabolism and morphology in a canine model of sepsis. Am J Physiol 266:H757-H768, 1994
75. Parrillo JE, Burch C, Shelhamer JH, et al: A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. J Clin Invest 76:1539-1553, 1985 (Pubitemid 16193573)
76. Reilly JM, Cunnion RE, Burch-Whitman C, et al: A circulating myocardial depressant substance is associated with cardiac dysfunction and peripheral hypoperfusion (lactic acidemia) in patients with septic shock. Chest 95:1072-1080, 1989 (Pubitemid 19137004)
77. Kumar A, Thota V, Dee L, et al: Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med 183:949-958, 1996 (Pubitemid 26113964)
78. Finkel MS, Oddis CV, Jacob TD, et al: Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257:387-389, 1992
79. Müller-Werdan U, Schumann H, Loppnow H, et al: Endotoxin and tumor necrosis factor alpha exert a similar proinflammatory effect in neonatal rat cardiomyocytes, but have different cardiodepressant profiles. J Mol Cell Cardiol 30:1027-1036, 1998 (Pubitemid 28279315)
80. Zell R, Geck P, Werdan K, et al: TNF-alpha and IL-1 alpha inhibit both pyruvate dehydrogenase activity and mitochondrial function in cardiomyocytes: Evidence for primary impairment of mitochondrial function. Mol Cell Biochem 177:61-67, 1997
81. Niederbichler AD, Hoesel LM, Westfall MV, et al: An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction. J Exp Med 203:53-61, 2006 (Pubitemid 43139645)
82. Pathan N, Hemingway CA, Alizadeh AA, et al: Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock. Lancet 363:203-209, 2004 (Pubitemid 38114718)
83. Mink SN, Jacobs H, Duke K, et al: N,N′,N″- triacetylglucosamine, an inhibitor of lysozyme, prevents myocardial depression in Escherichia coli sepsis in dogs. Crit Care Med 32:184-193, 2004 (Pubitemid 38125580)
84. Kumar A, Kumar A, Michael P, et al: Human serum from patients with septic shock activates transcription factors STAT1, IRF1, and NF-kappaB and induces apoptosis in human cardiac myocytes. J Biol Chem 280:42619-42626, 2005 (Pubitemid 43049220)
85. Yang M, Wu J, Martin CM, et al: Important role of p38 MAP kinase/NF-kappaB signaling pathway in the sepsis-induced conversion of cardiac myocytes to a proinflammatory phenotype. Am J Physiol Heart Circ Physiol 294:H994-H1001, 2008 (Pubitemid 351253313)
86. Abi-Gerges N, Tavernier B, Mebazaa A, et al: Sequential changes in autonomic regulation of cardiac myocytes after in vivo endotoxin injection in rat. Am J Respir Crit Care Med 160:1196-1204, 1999 (Pubitemid 29487459)
87. Mebazaa A, De Keulenaer GW, Paqueron X, et al: Activation of cardiac endothelium as a compensatory component in endotoxin-induced cardiomyopathy: Role of endothelin, prostaglandins, and nitric oxide. Circulation 104:3137-3144, 2001 (Pubitemid 34014071)
88. Massion PB, Feron O, Dessy C, et al: Nitric oxide and cardiac function: Ten years after, and continuing. Circ Res 93:388-398, 2003 (Pubitemid 37100003)
89. Cohen RI: Nitric oxide and cardiopulmonary failure in sepsis, in Scharf SM, Pinsky M, Magder S (eds): Heart Lung Interactions in Health and Disease (ed 2). New York, Marcel Dekker, Inc., 2001, pp 763-792
90. Flesch M, Kilter H, Cremers B, et al: Effects of endotoxin on human myocardial contractility involvement of nitric oxide and peroxynitrite. J Am Coll Cardiol 33:1062-1070, 1999
91. Kumar A, Brar R, Wang P, et al: Role of nitric oxide and cGMP in human septic serum-induced depression of cardiac myocyte contractility. Am J Physiol 276:R265-R276, 1999 (Pubitemid 29061717)
92. Barth E, Radermacher P, Thiemermann C, et al: Role of inducible nitric oxide synthase in the reduced responsiveness of the myocardium to catecholamines in a hyperdynamic, murine model of septic shock. Crit Care Med 34:307-313, 2006
93. Ichinose F, Hataishi R, Wu JC, et al: A selective inducible NOS dimerization inhibitor prevents systemic, cardiac, and pulmonary hemodynamic dysfunction in endotoxemic mice. Am J Physiol Heart Circ Physiol 285:H2524-H2530, 2003 (Pubitemid 37443070)
94. Ullrich R, Scherrer-Crosbie M, Bloch KD, et al: Congenital deficiency of nitric oxide synthase 2 protects against endotoxin-induced myocardial dysfunction in mice. Circulation 102:1440-1446, 2000
95. Grover R, Zaccardelli D, Colice G, et al: An open-label dose escalation study of the nitric oxide synthase inhibitor, N(G)-methyl-Larginine hydrochloride (546C88), in patients with septic shock. Glaxo Wellcome International Septic Shock Study Group. Crit Care Med 27:913-922, 1999
96. Wink DA, Miranda KM, Espey MG: Cytotoxicity related to oxidative and nitrosative stress by nitric oxide. Exp Biol Med 226:621-623, 2001 (Pubitemid 32619597)
97. Geoghegan-Morphet N, Burger D, Lu X, et al: Role of neuronal nitric oxide synthase in lipopolysaccharide-induced tumor necrosis factor-alpha expression in neonatal mouse cardiomyocytes. Cardiovasc Res 75:408-416, 2007 (Pubitemid 46961921)
98. Cohen RI, Wilson D, Liu SF: Nitric oxide modifies the sarcoplasmic reticular calcium release channel in endotoxemia by both cGMP-dependent and independent pathways. Crit Care Med 34:173-181, 2006 (Pubitemid 43032395)
99. Matthew FW, Hess DT, Stamler JS: Protein S-nitrosylation in health and disease: A current perspective. Trends Mol Med 15:391-404, 2009
100. Rudiger A, Singer M: Mechanisms of sepsis-induced cardiac dysfunction. Crit Care Med 35:1599-1608, 2007 (Pubitemid 46809326)
101. Iwase M, Yokota M, Kitaichi K, et al: Cardiac functional and structural alterations induced by endotoxin in rats: Importance of platelet-activating factor. Crit Care Med 29:609-617, 2001 (Pubitemid 32225305)
102. Hahn PY, Wang P, Tait SM, et al: Sustained elevation in circulating catecholamine levels during polymicrobial sepsis. Shock 4:269-273, 1995
103. Tang C, Liu MS: Initial externalization followed by internalization of beta-adrenergic receptors in rat heart during sepsis. Am J Physiol 270:R254-R263, 1996
104. Shepherd RE, Lang CH, McDonough KH. Myocardial adrenergic responsiveness after lethal and nonlethal doses of endotoxin. Am J Physiol 252:H410-H416, 1987
105. Matsuda N, Hattori Y, Akaishi Y, et al: Impairment of cardiac beta-adrenoceptor cellular signaling by decreased expression of G(s alpha) in septic rabbits. Anesthesiology 93:1465-1473, 2000
106. Wu LL, Yang SL, Yang RC, et al: G protein and adenylate cyclase complex-mediated signal transduction in the rat heart during sepsis. Shock 19:533-537, 2003
107. Bohm M, Kirchmayr R, Gierschik P, et al: Increase of myocardial inhibitory G-proteins in catecholamine-refractory septic shock or in septic multiorgan failure. Am J Med 98:183-186, 1995
108. Sharshar T, Annane D, de la Grandmaison GL et al: The neuropathology of septic shock. Brain Pathol 14:21-33, 2004 (Pubitemid 38200586)
109. Sharshar T, Gray F, Lorin de la Grandmaison G, et al: Apoptosis of neurons in cardiovascular autonomic centres triggered by inducible nitric oxide synthase after death from septic shock. Lancet 362:1799-1805, 2003 (Pubitemid 37494758)
110. Cariou A, Pinsky MR, Monchi M, et al: Is myocardial adrenergic responsiveness depressed in human septic shock? Intensive Care Med 34:917-922, 2008
111. Zhong J, Hwang TC, Adams HR, et al: Reduced L-type calcium current in ventricular myocytes from endotoxemic guinea pigs. Am J Physiol 273:H2312-2324, 1997
112. Liu S, Schreur KD: G protein-mediated suppression of L-type Ca2+ current by interleukin-1 beta in cultured rat ventricular myocytes. Am J Physiol 268:C339-C349, 1995
113. Wu LL, Ji Y, Dong LW, et al: Calcium uptake by sarcoplasmic reticulum is impaired during the hypodynamic phase of sepsis in the rat heart. Shock 15:49-55, 2001 (Pubitemid 33598160)
114. Dong LW, Wu LL, Ji Y, et al: Impairment of the ryanodinesensitive calcium release channels in the cardiac sarcoplasmic reticulum and its underlying mechanism during the hypodynamic phase of sepsis. Shock 16:33-39, 2001 (Pubitemid 33598185)
115. Lew WY, Yasuda S, Yuan T, et al: Endotoxin-induced cardiac depression is associated with decreased cardiac dihydropyridine receptors in rabbits. J Mol Cell Cardiol 28:1367-1371, 1996 (Pubitemid 26174428)
116. Tavernier B, Garrigue D, Boulle C, et al: Myofilament calcium sensitivity is decreased in skinned cardiac fibres of endotoxin-treated rabbits. Cardiovasc Res 38:472-479, 1998 (Pubitemid 28294165)
117. Tavernier B, Mebazaa A, Mateo P, et al: Phosphorylation-dependent alteration in myofilament ca2+ sensitivity but normal mitochondrial function in septic heart. Am J Respir Crit Care Med 163:362-367, 2001 (Pubitemid 32158513)